Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “labelling”
ButOx Human Trial: An Open Label Prospective Cohort Study to Investigate the Effect of Tributyrin (Butyrate Precursor Molecule) Supplementation on Markers of Calcium Oxalate Nephrolithiasis
ClinicalTrials.gov study NCT07004257. IPD Sharing: NO. Countries: 1. Publications: 0.
De-labeling of Patients With False Diagnosis of Penicillin Allergy
ClinicalTrials.gov study NCT03581604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase
ClinicalTrials.gov study NCT02368717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD Patients
ClinicalTrials.gov study NCT00335374. IPD Sharing: Not stated. Countries: 15. Publications: 0.
A Phase 1,Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
ClinicalTrials.gov study NCT05315180. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT00314912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
ClinicalTrials.gov study NCT06836232. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Molecular Imaging Research of F-18 Labeled DX600 PET Probe
ClinicalTrials.gov study NCT04542863. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day
ClinicalTrials.gov study NCT00879983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
ClinicalTrials.gov study NCT05687266. IPD Sharing: YES. Countries: 23. Publications: 0.
An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates
ClinicalTrials.gov study NCT00850122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-dose, Open-label, Parallel-group Study to Assess the Pharmacokinetics of BAF312 in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function
ClinicalTrials.gov study NCT01904214. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open-Label Study to Evaluate Retreatment With LIPO-202
ClinicalTrials.gov study NCT02397525. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
ClinicalTrials.gov study NCT00165880. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
ClinicalTrials.gov study NCT00195754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-
ClinicalTrials.gov study NCT00179699. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the
ClinicalTrials.gov study NCT01281098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Duloxetine Monotherapy in the Treatment of Posttraumatic Stress Disorder
ClinicalTrials.gov study NCT00583193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally
ClinicalTrials.gov study NCT05572255. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers
ClinicalTrials.gov study NCT06169579. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.